Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults

BACKGROUND. There are no clinical trials specifically addressing chemotherapy for adults with Ewing sarcoma (ES). Five‐year event‐free survival (EFS) of adults on pediatric studies of ES (44%–47%) is worse than that of children treated with the same therapy (69%). The object of this study was to rev...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncologist
Päätekijät: Wagner, Michael J., Gopalakrishnan, Vancheswaran, Ravi, Vinod, Livingston, J. Andrew, Conley, Anthony P., Araujo, Dejka, Somaiah, Neeta, Zarzour, Maria A., Ratan, Ravin, Wang, Wei-Lien, Patel, Shreyaskumar R., Lazar, Alexander, Ludwig, Joseph A., Benjamin, Robert S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AlphaMed Press 2017
Aiheet:
Sarcomas
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5634776/
https://ncbi.nlm.nih.gov/pubmed/28710342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0464
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia